Essential Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$673K Sell
2,543
-53
-2% -$14K 0.31% 52
2026
Q2
$659K Sell
2,596
-4,461
-63% -$1.04M 0.3% 58
2026
Q1
$1.73M Sell
7,057
-63
-0.9% -$14.7K 0.58% 34
2025
Q4
$1.47M Buy
7,120
+59
+0.8% +$11.7K 0.45% 49
2025
Q3
$1.31M Sell
7,061
-269
-4% -$46.1K 0.43% 48
2025
Q2
$1.12M Buy
+7,330
New +$1.13M 0.45% 52

Other funds holding JNJ

Essential Partners's JNJ Position: Q3 2026 in Review

Essential Partners reduced its Johnson & Johnson (JNJ) stake by 2% in Q3 2026, selling an estimated $14K and leaving 2,543 shares worth $673K. The position accounts for 0.31% of the portfolio, ranked #52.

Essential Partners first reported a position in JNJ in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.73M in Q1 2026. 872 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Essential Partners held 2,543 shares of Johnson & Johnson worth $673K as of Q3 2026.
  • Essential Partners sold 53 Johnson & Johnson shares in Q3 2026, an estimated $14K.
  • Johnson & Johnson made up 0.31% of Essential Partners's portfolio in Q3 2026, its #52 holding.
  • Essential Partners first reported a position in Johnson & Johnson in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Johnson & Johnson position peaked at $1.73M in Q1 2026.
  • 872 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.